January 2021
FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Seno’s Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
[SAN ANTONIO, TX – January 19, 2021] The Center for Devices and Radiological Health (CDRH) of the US […]November 2019
Seno Medical and “Know Your Lemons” Highlight Importance of Education and Self-Exam for Early Breast Cancer Detection
New survey demonstrates women play a critical role in symptom(s) discovery
SAN ANTONIO, Nov. 14, 2019 /PRNewswire/ — A recent survey of women in the Netherlands found that 79 percent of respondents diagnosed with breast cancer noticed symptoms prior to being […]
September 2019
Additional Research Published In Radiology Demonstrates Application Of Ground-Breaking Breast Cancer Diagnostic Technology
Seno Medical’s opto-acoustic technology could differentiate between breast cancer types
SAN ANTONIO, Sept. 19, 2019 /PRNewswire/ — An article recently published in Radiology highlights the groundbreaking use of a new imaging technology introduced by Seno Medical Instruments, Inc.® (Seno Medical) to […]
June 2019
European Radiology Profiles Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Seno Medical’s opto-acoustic technology could reduce false positives and identify cancer sub-types
SAN ANTONIO, June 19, 2019 /PRNewswire/ — Additional research appearing in the June online issue (open access) of European Radiology features the groundbreaking diagnostic breast […]
May 2019
Seno Medical and “Know Your Lemons” Team Up For Breast Cancer Education
Partnership emphasizes breast health education and empowers women
SAN ANTONIO, May 12, 2019 – Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, […]
January 2019
Multiple Publications and Presentations Underscore Seno Medical’s Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies
SAN ANTONIO, January 8, 2019 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data […]
In the News
View featured storiesView featured stories
Media Kit
View Media KitView Media Kit
Sign Up
Receive updates when we post a new press release.Sign up to receive updates when we post a new press release.